Aquarius Surgical Technologies Inc. of Toronto promoted Gordon Willox to the position of president and chief technical officer. Willox was serving as the managing director of Aquarius. The company also reported the closing of a note transaction to provide $750,000 in working capital, which will be applied toward marketing and sales activities and general corporate purposes.
Palo Alto Health Sciences Inc. of Kirkland, Wash., appointed Christopher Lento the company's chief commercial officer. Lento previously worked at Pear Therapeutics and will lead Palo Alto's efforts to expand the market share of its Freespira, an FDA-cleared digital therapeutic for panic-related disorders.
Transmed Systems Inc. of Memphis has appointed Carla Balch as CEO, the second in the company's history. Balch had previously served as the president of Nantcare, an oncology clinical trial company. The company also named Jeff Edenfield as its first chief medical officer.